Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
927.15
3.50 (0.38%)
< Home < Back

Natco Pharma reports 27% rise in Q3 consolidated net profit

Date: 16-02-2022

Natco Pharma has reported results for third quarter ended December 31, 2021.

The company has reported rise of 30.90% in its net profit at Rs 71.60 crore for the quarter under review as compared to Rs 54.70 crore for the same quarter in the previous year. Total income of the company increased by 57.70% at Rs 561.10 crore for Q3FY22 as compared Rs 355.80 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 26.81% in its net profit at Rs 80.40 crore for the quarter under review as compared to Rs 63.40 crore for the same quarter in the previous year. Total income of the company increased by 53.03% at Rs 590.70 crore for Q3FY22 as compared Rs 386.00 crore for the corresponding quarter previous year.